Funding
← Back to your selection

HealthCap

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$89M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series C+1

By primary sector

Biotech1
Healthtech1

By country

Denmark1
Finland1

Rounds

2 in this selection
CurifyLabs

CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines.

$14MSeries A
Role not disclosed
Adcendo

Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.

$75MSeries C
Role not disclosed